Milliman's $37,824 Health-Cost Number Belongs on the Payroll Desk

TL;DR: Milliman's May 20 medical-cost estimate says a typical employer-sponsored family health plan will cost $37,824 in 2026, with average per-person costs rising 7.9%. That is not just an insurance headline. It is a payroll headline, because every renewal meeting now forces employers to decide how much of the wage budget gets quietly rerouted to outpatient facilities, pharmacy claims, deductibles, and plan design.

##What Milliman's 2026 Health-Cost Number Actually Says

The clean number is the ugly one: Milliman estimates that healthcare costs for a typical family of four covered by employer-sponsored insurance will reach $37,824 in 2026.

For the average covered person, Milliman puts the figure at $8,460, up from $7,838 in 2025. That is a 7.9% increase, the highest Milliman Medical Index increase in more than a decade if the COVID-period distortions are set aside.

The usual reaction is to file this under "health insurance is expensive." That is too soft.

This is a compensation story. A $37,824 family-health tab sits in the same economic room as raises, hiring plans, bonuses, price increases, and margin targets. The employee may see a premium deduction. The employer sees a renewal invoice that competes with payroll before anyone says the word wage.

##Why This Belongs on the Payroll Desk

The best place to understand the story is not a hospital. It is a conference table with an HR lead, a finance manager, a broker, a spreadsheet, and a renewal packet.

The broker points to trend. Finance asks what happens if the deductible moves. HR asks how much pain employees will tolerate. Someone tries to protect wages. Someone else quietly notices that the health plan already ate part of the raise pool.

That is the mechanism casual readers miss.

#Who really pays when medical trend outruns wage growth?

Employers can absorb the increase, pass more cost to workers, narrow networks, raise deductibles, change pharmacy rules, or trim elsewhere. None of those choices is free.

Mercer's employer-plan survey says average health benefit cost per employee rose 6.0% in 2025 and is projected to rise 6.7% in 2026, which it describes as the highest projected increase in 15 years. Different surveys use different populations and methods, but the direction is not subtle.

When health costs rise faster than ordinary labor budgets, the hidden tradeoff looks like this:

less room for broad wage increases
more pressure to shift cost sharing to employees
tougher benefit negotiations for small and mid-sized employers
more interest in pharmacy management, narrower networks, and care-navigation vendors
a cleaner advantage for employers big enough to negotiate better terms

That last point matters. Healthcare inflation is not evenly distributed as business pain. Scale becomes a benefits advantage.

##Where The Cost Pressure Is Coming From

Milliman says outpatient facility care and pharmacy services are the main drivers in 2026, contributing 69% of the year-over-year increase in its index.

That mix matters because it moves the fight away from the old image of a hospital bill as a rare catastrophe. The pressure is now built into recurring plan usage, specialty drugs, outpatient sites, and benefit-management rules that employees experience in small moments.

#Why GLP-1 drugs change the renewal conversation

Milliman specifically calls out GLP-1 drugs for diabetes and weight-loss management as a meaningful and growing part of pharmacy spend. Mercer also points to prescription-drug spending, helped by GLP-1 utilization, as a key 2025 cost driver.

The finance problem is not that these drugs are useless. The harder problem is that a drug can be clinically valuable, employee-desired, and financially explosive at the same time.

That is where the CFO's spreadsheet gets uncomfortable. Covering a popular drug class can improve health outcomes and employee satisfaction, but broad access can turn pharmacy benefits into a much larger recurring claim stream. Restricting access can save money, but it creates workplace frustration and pushes HR into medical-adjudication arguments it never wanted to own.

The employer is no longer simply buying insurance. It is managing a health-cost product with social expectations attached.

##Who Gains Pricing Power From This

Rising employer-plan costs do not just hurt households. They create commercial winners.

Large insurers, pharmacy benefit managers, care-navigation firms, specialty-drug managers, benefits consultants, and employer-health vendors all have a stronger sales pitch when the renewal packet arrives with a number that scares finance. The pitch is simple: pay us to reduce the bigger number.

That does not mean every vendor saves money. It means the budget owner is under enough pressure to listen.

For investors, the more useful lens is not "healthcare costs are high." It is: which companies sit between the employer and the claim, and can they prove measurable savings before the next renewal cycle?

For employers, the useful lens is even blunter. A benefits vendor that cannot lower trend, improve steerage, reduce waste, or make pharmacy rules more defensible is just another line item joining the cost pile.

##Why The Investor Angle Is Not Just Health Insurance

The investable story stretches past health insurers.

Employer healthcare inflation touches consumer spending, wage growth, small-business margins, labor retention, and enterprise software budgets. A worker whose family premium and out-of-pocket exposure keep rising has less discretionary room. A company absorbing more benefit cost has less space for hiring or wage expansion.

That is why the Milliman number belongs in a broader business dashboard. It is a quiet tax on labor markets, but unlike payroll tax, it moves through plan documents, pharmacy coverage rules, and renewal meetings.

The sharpest takeaway is not that the U.S. healthcare system is expensive. Everyone knows that.

The sharper point is that employer-sponsored insurance turns medical inflation into a management decision every year. Somebody has to decide whether the next dollar goes to wages, margins, prices, or claims.

That is a business model, not just a benefit.

##FAQ

#What is the Milliman Medical Index?

The Milliman Medical Index estimates annual healthcare costs for people covered by a typical U.S. employer-sponsored preferred provider organization plan. The 2026 estimate is $37,824 for a family of four and $8,460 for an average person.

#Why does this matter for investors?

It affects more than insurers. Employer health-cost inflation can shape wage growth, consumer cash flow, small-business margins, pharmacy-benefit demand, and the market for vendors that promise to control claims.

#What is the main business risk for employers?

The risk is that health-plan renewals absorb money that employees expected to see as wages or that companies expected to keep as margin. If the cost shift becomes too visible, benefits stop being a retention tool and start becoming a workplace grievance.